Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corticosteroid-refractory Chronic Graft vs. Host Disease”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Testing effectiveness (Phase 2)Study completedNCT00054613
What this trial is testing

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Mallinckrodt 72
Large-scale testing (Phase 3)Study completedNCT02959944
What this trial is testing

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Pharmacyclics LLC. 193
Post-approval studies (Phase 4)Looking for participantsNCT06824103
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Who this might be right for
Graft vs. Host DiseaseChronic Graft vs. Host DiseaseCorticosteroid-refractory Chronic Graft vs. Host Disease
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Testing effectiveness (Phase 2)Study completedNCT02841995
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Kadmon, a Sanofi Company 54
Testing effectiveness (Phase 2)Study completedNCT03790332
What this trial is testing

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Pharmacyclics LLC. 59